Location History:
- Lund, SE (2006 - 2016)
- Molndal, SE (2017)
Company Filing History:
Years Active: 2006-2017
Title: Thomas Hansson: Innovator in Pharmaceutical Chemistry
Introduction
Thomas Hansson is a notable inventor based in Lund, Sweden. He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 7 patents. His work primarily focuses on novel compounds that have potential medicinal applications.
Latest Patents
One of Hansson's latest patents involves phenyl and benzodioxinyl substituted indazoles derivatives. This invention relates to novel indazolyl derivatives, which are crucial for developing pharmaceutical compositions. The patent outlines processes for preparing these derivatives and their use as medicaments, showcasing Hansson's commitment to advancing medical science.
Career Highlights
Throughout his career, Thomas Hansson has worked with prominent companies in the pharmaceutical industry, including AstraZeneca AB and Bayer Schering Pharma AG. His experience in these organizations has allowed him to refine his expertise and contribute to groundbreaking research in drug development.
Collaborations
Hansson has collaborated with several talented individuals in his field, including Markus Berger and Karl Henrik Edman. These partnerships have fostered innovation and have been instrumental in the success of his projects.
Conclusion
Thomas Hansson's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as a key innovator in the industry. His work continues to impact the development of new medicinal compounds.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.